Medical Communications

Health officials have declared a state of emergency in Washington as an outbreak of measles continues to spread. As January …

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …

400 Pfizer employees are set to go on strike in Ireland over an ongoing pensions dispute. Members of SITPU, Ireland’s …

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …

A pharmaceutical executive working for Insys therapeutics has been accused of giving a doctor a lap dance in an effort …

OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …

Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …

Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …